Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

European Union

BMA warns of 'catastrophic' effect on health of no-deal Brexit

In a briefing paper, the British Medical Association says that leaving the EU without a deal in place would be a “catastrophe” for British healthcare.

A no-deal Brexit could be a catastrophe for NHS services and workforce, patients and the health of the nation, the British Medical Association (BMA) has warned.

In the event of the UK leaving the EU without an agreement, the UK would be outside the European Rare Diseases Network, which the BMA claims would disrupt the treatment of 1 million patients.

It also warns that the UK’s ability to tackle pandemics would be weakened because it would lose access to the European Centre for Disease and Prevention Control, the agency devoted to strengthening EU defences against infectious diseases.

It also says a no-deal scenario would also have an impact on doctor workforce mobility if a hard border was reinstated between Northern Ireland and the Republic of Ireland, and because of doubts over the mutual recognition of professional qualifications.

The UK government announced in its Brexit white paper that it would like to see continued cross-border recognition of seven professions, including doctors and pharmacists, after Brexit. But this would be contingent on a deal being agreed.

The warnings come in a briefing paper produced by the BMA, members of which supported the campaign for the public to have a say on any final Brexit deal, at the organisation’s annual conference held in Brighton in June 2018.

Chaand Nagpaul, chair of the BMA council, said: “Some will say we are scaremongering by warning of the dangers of a ‘no-deal’ Brexit, but this is not the case.

“We aren’t shying away from being honest about what is at stake for health services if the UK and the EU fail to reach a deal. As experts in delivering health services and providing care for our patients, we have a duty to set out the consequences of leaving the EU with no future deal in place.”

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2018.20205329

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.